Oncology
Data on oncology detailed by researchers at University of Florida, Department of Biomedical Engineering
Published in Blood Weekly, December 23rd, 2010
2010 DEC 23 -- Investigators publish new data in the report 'In vivo functional differences in microvascular response of 4T1 and Caki-1 tumors after treatment with OXi4503.' According to a study from the United States, "4T1 mouse mammary adenocarcinomas and Caki-1 human renal cell carcinomas grown in mouse dorsal window chambers were serially treated with the vascular disrupting agent (VDA) OXi4503 and their responses compared. The real-time in vivo response was assessed using spectral imaging of microvascular hemoglobin saturation."
"To our knowledge this is the first use of spectral imaging technology for investigation of vascular disrupting agents....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-12-23)
More Articles from Blood Weekly
- Diet and Nutrition
Scientists at University of Sao Paulo publish new data on diet and nutrition - BioTime, Inc.
BioTime Plans Warrant Distribution to Shareholders - Transplantation
Data on transplantation discussed by researchers at Harvard University - Blood Safety
Fidelity Janitorial has adopts emPower eLearning Solutions Bloodborne Pathogens Standard Online Course. - Cardiac Surgical Procedures
Findings from G. Bruschi and co-authors provide new insights into cardiac surgical procedures - Stem Cell Research
GeneCell International Opens Miami-Based Headquarters, First and Only Cord Blood Processing and Cryogenic Storage Laboratory in Miami - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
